The effect of short-term aerobic training on coagulation and fibrinolytic factors in sedentary healthy postmenopausal women. 2009

Tahereh Jahangard, and Giti Torkaman, and Babak Ghoosheh, and Mehdi Hedayati, and Azadeh Dibaj
Physical Therapy Department, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, PO Box 14115-331, Islamic Republic of Iran.

OBJECTIVE The purpose of this study was to assess the effect of short-term aerobic training on the fibrinolytic and coagulative factors in postmenopausal women. METHODS Twenty volunteer sedentary healthy postmenopausal women (48-53 years), who entered the menopause naturally, were divided randomly into two groups: training (n=10) and control (n=10). METHODS Training consisted of 10 sessions of submaximal aerobic cycling, 35 min for each session (5 min warm-up, 25 min aerobic training with 70% HRmax, 5 min active and 15 min passive recovery), 3 times a week. Coagulation and fibrinolytic factors were assessed both before and after aerobic program in both groups. RESULTS Fibrinogen, von Willbrand factor (vWF-Ag) antigen, plasminogen activator inhibitor-1 activity (PAI-1:Ac) and antigen (PAI-1:Ag) showed significant reduction after 10 sessions in the training group (P<0.05). Also after training, prothrombin time (PT), partial thromboplastin time (PTT), tissue plasminogen activator activity (tPA:Ac) and antigen (tPA:Ag) increased (P<0.05). CONCLUSIONS It was concluded that fibrinolytic activity on postmenopausal women could be improved by a 3-week regular submaximal training program. These changes on the hemostatic factors suggest that short-term aerobic training may prevent the decline in fibrinolytic function observed in sedentary postmenopausal women.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010314 Partial Thromboplastin Time The time required for the appearance of FIBRIN strands following the mixing of PLASMA with phospholipid platelet substitute (e.g., crude cephalins, soybean phosphatides). It is a test of the intrinsic pathway (factors VIII, IX, XI, and XII) and the common pathway (fibrinogen, prothrombin, factors V and X) of BLOOD COAGULATION. It is used as a screening test and to monitor HEPARIN therapy. Activated Partial Thromboplastin Time,Cephalin-Kaolin Coagulation Time,Kaolin-Cephalin Coagulation Time,Thromboplastin Time, Partial,Coagulation Time, Cephalin-Kaolin,Cephalin Kaolin Coagulation Time,Coagulation Time, Cephalin Kaolin,Coagulation Time, Kaolin-Cephalin,Kaolin Cephalin Coagulation Time
D011517 Prothrombin Time Clotting time of PLASMA recalcified in the presence of excess TISSUE THROMBOPLASTIN. Factors measured are FIBRINOGEN; PROTHROMBIN; FACTOR V; FACTOR VII; and FACTOR X. It is used for monitoring anticoagulant therapy with COUMARINS. Quick Test,Russell's Viper Venom Time,Thrombotest,Russell Viper Venom Time,Russells Viper Venom Time,Prothrombin Times,Test, Quick,Time, Prothrombin,Times, Prothrombin
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D001779 Blood Coagulation Factors Endogenous substances, usually proteins, that are involved in the blood coagulation process. Clotting Factor,Coagulation Factors,Blood Coagulation Factor,Clotting Factors,Coagulation Factor,Coagulation Factor, Blood,Coagulation Factors, Blood,Factor, Coagulation,Factors, Coagulation,Factor, Blood Coagulation,Factor, Clotting,Factors, Blood Coagulation,Factors, Clotting
D005260 Female Females
D005340 Fibrinogen Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products. Coagulation Factor I,Factor I,Blood Coagulation Factor I,gamma-Fibrinogen,Factor I, Coagulation,gamma Fibrinogen
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000941 Antigens Substances that are recognized by the immune system and induce an immune reaction. Antigen

Related Publications

Tahereh Jahangard, and Giti Torkaman, and Babak Ghoosheh, and Mehdi Hedayati, and Azadeh Dibaj
November 2015, Lipids in health and disease,
Tahereh Jahangard, and Giti Torkaman, and Babak Ghoosheh, and Mehdi Hedayati, and Azadeh Dibaj
March 2001, Journal of internal medicine,
Tahereh Jahangard, and Giti Torkaman, and Babak Ghoosheh, and Mehdi Hedayati, and Azadeh Dibaj
January 2009, Menopause (New York, N.Y.),
Tahereh Jahangard, and Giti Torkaman, and Babak Ghoosheh, and Mehdi Hedayati, and Azadeh Dibaj
October 2009, International journal of clinical practice,
Tahereh Jahangard, and Giti Torkaman, and Babak Ghoosheh, and Mehdi Hedayati, and Azadeh Dibaj
September 2014, Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia,
Tahereh Jahangard, and Giti Torkaman, and Babak Ghoosheh, and Mehdi Hedayati, and Azadeh Dibaj
March 1999, Clinical endocrinology,
Tahereh Jahangard, and Giti Torkaman, and Babak Ghoosheh, and Mehdi Hedayati, and Azadeh Dibaj
May 1998, JAMA,
Tahereh Jahangard, and Giti Torkaman, and Babak Ghoosheh, and Mehdi Hedayati, and Azadeh Dibaj
February 2008, Nutrition (Burbank, Los Angeles County, Calif.),
Tahereh Jahangard, and Giti Torkaman, and Babak Ghoosheh, and Mehdi Hedayati, and Azadeh Dibaj
February 1977, Atherosclerosis,
Tahereh Jahangard, and Giti Torkaman, and Babak Ghoosheh, and Mehdi Hedayati, and Azadeh Dibaj
June 1999, Climacteric : the journal of the International Menopause Society,
Copied contents to your clipboard!